Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Expensify (EXFY) Cash from Financing Activities (2020 - 2025)

Expensify (EXFY) has disclosed Cash from Financing Activities for 6 consecutive years, with -$1.2 million as the latest value for Q4 2025.

  • Quarterly Cash from Financing Activities fell 30.01% to -$1.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.7 million through Dec 2025, up 87.57% year-over-year, with the annual reading at -$2.7 million for FY2025, 87.57% up from the prior year.
  • Cash from Financing Activities hit -$1.2 million in Q4 2025 for Expensify, down from -$1.1 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $63.0 million in Q4 2021 to a low of -$34.9 million in Q4 2023.
  • Historically, Cash from Financing Activities has averaged $107450.0 across 5 years, with a median of -$988000.0 in 2021.
  • Biggest five-year swings in Cash from Financing Activities: skyrocketed 19344.75% in 2021 and later crashed 3537.37% in 2024.
  • Year by year, Cash from Financing Activities stood at $63.0 million in 2021, then crashed by 109.81% to -$6.2 million in 2022, then tumbled by 465.47% to -$34.9 million in 2023, then surged by 97.44% to -$893000.0 in 2024, then plummeted by 30.01% to -$1.2 million in 2025.
  • Business Quant data shows Cash from Financing Activities for EXFY at -$1.2 million in Q4 2025, -$1.1 million in Q3 2025, and -$1.7 million in Q2 2025.